2001
DOI: 10.1074/jbc.m100278200
|View full text |Cite
|
Sign up to set email alerts
|

c-Jun Binds the N Terminus of Human TAFII250 to Derepress RNA Polymerase II Transcription in Vitro

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
51
0

Year Published

2001
2001
2023
2023

Publication Types

Select...
10

Relationship

3
7

Authors

Journals

citations
Cited by 37 publications
(51 citation statements)
references
References 46 publications
0
51
0
Order By: Relevance
“…A number of factors, including activators (i.e., c-Jun and VP16) and TFIIA, can stimulate TFIID/ promoter binding by derepressing the TAF1-mediated inhibition of TBP (19,(48)(49)(50)(51). TFIIA has also been found to aid conversion of canonical TFIID to the rearranged DNA binding form, likely via disruption of TBP/TAF1 TAND interactions (26,27).…”
Section: Discussionmentioning
confidence: 99%
“…A number of factors, including activators (i.e., c-Jun and VP16) and TFIIA, can stimulate TFIID/ promoter binding by derepressing the TAF1-mediated inhibition of TBP (19,(48)(49)(50)(51). TFIIA has also been found to aid conversion of canonical TFIID to the rearranged DNA binding form, likely via disruption of TBP/TAF1 TAND interactions (26,27).…”
Section: Discussionmentioning
confidence: 99%
“…Reversibility of this concave inhibition would be a key feature to allow TBP to bind DNA. It has been proposed that transcriptional activators like c-Jun, VP16, GAL4, and EBNA2 may regulate dTAF II 230/hTAF II 250 inhibition of TBP binding to DNA (30,32,35,41). Might hTAF II 170 inhibition of TBP be similarly modulated?…”
Section: Discussionmentioning
confidence: 99%
“…An increasing amount of evidence suggests that the TAND participates in transcriptional activation even though it is not absolutely required (5,6,8,14,15,29). For example, the TBP-inhibitory activity of human TAF1 can be reduced in vitro by the action of the AD (14,15).…”
mentioning
confidence: 99%